Aptose Biosciences buy melinda
Start price
14.12.21
/
50%
€0.98
Target price
14.12.22
-
Performance (%)
-39.08%
End price
15.12.22
€0.60
Summary
This prediction ended on 15.12.22 with a price of €0.60. Massive losses of -39.08% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Aptose Biosciences | - | - | - |
iShares Core DAX® | -0.922% | -1.078% | 12.165% |
iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to melinda what are the pros and cons of Aptose Biosciences for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Aptose Biosciences diskutieren
Buy Aptose Biosciences
In the thread Trading Aptose Biosciences
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Aptose Biosciences
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
24.03.21
24.03.21
€5.50
24.03.22
24.03.22
-15.64%
01.05.21
01.05.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
12.01.20
12.01.20
-
04.11.21
04.11.21
0.00%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.08
11.12.19
11.12.19
-
12.01.20
12.01.20
34.80%
12.01.20
12.01.20
Could be worthwhile Investment >10% per year
Aptose Biosciences
Start price
Target price
Perf. (%)
€1.81
26.05.19
26.05.19
€2.71
05.07.19
05.07.19
49.91%
05.07.19
05.07.19
Could be worthwhile Investment >10% per year